About Us
Asia Air WatchLive PM2.5 Medical Alerts
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Functional Unblinding and Its Implications for the Internal Validity of Randomized Controlled Clinical Trials: The Science May Be Nuanced.

Researchers

Chittaranjan Andrade

Abstract

The randomized clinical trial (RCT) is a gold-standard research design for the evaluation of cause and effect in medical disciplines. Fidelity of patient and rater blinding is one of many variables that support the internal validity of RCTs. When drugs have known, common, discernible psychological or somatic effects, experience or lack of experience of these effects can result in patients recognizing that they are receiving drug or placebo, respectively. Such functional unblinding can enhance or reduce treatment expectations and magnify or diminish placebo mechanisms, depending on whether patients are receiving drug or placebo. The internal validity of the study is thereby compromised. This article discusses blinding, the need for blinding, indices suggested for quantifying the integrity of blinding, questions that need to be asked to assess blinding, why assessing blinding only at study endpoint is desirable for ethical and scientific reasons, and the complexities of interpreting unblinding. It is suggested that, first, unblinding should not be interpreted merely as a yes or no result; it should be interpreted in the context of why it happened. Second, unblinding should not be presented as a standalone finding; it should be interpreted in the context of how it affects internal and external validity. Third, whether or not unblinding is considered to affect internal validity depends on whether internal validity is rigidly defined or defined with nuances. Finally, internal validity need not be a sacred cow; external validity may trump internal validity in certain contexts. A Blinding Internal Validity Index is suggested: this is the percentage of patients in whom unblinding has not compromised internal validity, with internal validity defined narrowly or broadly, as per the preference of the investigator.
Source: PubMed (PMID: 43055663)View Original on PubMed